Pharmaceutics Webinar | 3D and 4D Printing in Pharmaceutics
8 Feb 2023, 10:00 (CET)
3D Printing, 4D Printing, Additive Manufacturing, Controlled Drug Delivery, Personalized Medicine, Regulatory
Welcome from the Chair
2nd Pharmaceutics Webinar
3D and 4D Printing in Pharmaceutics
The 3D printing process patented in 1986; however, only in the last decade has it been used for medical applications, as well as being utilised in the fields of biofabrication and pharmaceutical printing. The additive manufacturing term involves many processes, which use different types of printing technologies, hundreds of materials, and various resolutions and speeds. 3D printing and 4D printing techniques allow for a patient-center approach. 3D printing allows the manufacturing of complex drug delivery devices, and with innovations in pharmaceutical development and an interdisciplinary approach to finding newer drug-delivery systems, can usher in a new era of treatments to various diseases. The introduction of the fourth dimension (4D Printing) has led to an increase in the degree of complexity and customization possibilities. This Webinar will present some new development in 3D & 4D Printing for pharmaceutical applications, including some regulatory considerations in the design and manufacturing of pharmaceutical products.
Date: 8 February 2023
Time: 10:00 am CET | 4:00 am EST | 5:00 pm CST Asia
Webinar ID: 826 0115 6308
Webinar Secretariat: email@example.com
School of Pharmacy, Queen’s University Belfast, UK
Dimitrios Lamprou is Full Professor (Chair) of Biofabrication and Advanced Manufacturing at Queen’s University Belfast, and a subject matter expert in emerging (bio)pharmaceutical technologies for drug delivery systems and medical implants. Dimitrios has been recognized as world leader in Printing with PubMed-based algorithms placed him in the top 0.047% of scholars in the world writing about Printing in the last 10 years. Dimitrios, is the author of over 140 peer-reviewed publications, has over 350 conference abstracts, has given over 140 Invited Talks in institutions and conferences across the world, and has secure Funding in excess of £2.5M. His research and academic leadership have been recognized in a range of awards, including the Royal Pharmaceutical Society Science Award and the Scottish Universities Life Sciences Alliance Leaders Scheme Award. For more info, please check at www.emergingtechnologieslab.com.
Pharmaceutics and Food Technology Department, School of Pharmacy, Universidad Complutense de Madrid, Spain
Dolores Serrano finished her PhD in 2013 at the Universidad Complutense of Madrid in the development of novel antimicrobials nanomedicines. Afterward, she worked as a postdoctoral Fellow at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin (Ireland) as part of the research group of Prof. Anne Marie Healy and a powerful consortium "SSPC" (Synthesis and Solid-State Pharmaceutical Center). Dolores joined Complutense University as Assistant Professor in October 2015 and become a senior lecturer in 2020. Since then, her work has focused on the use of 3D printing technologies for innovative medicines such as polypills, implants to prevent microbial infections and microfluidic chips for continuous manufacturing of nanomedicines.
Sezione di Tecnologia e Legislazione Farmaceutiche “Maria Edvige Sangalli”, Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Italy
She is Associate professor at the Department of Pharmaceutical Sciences of Università degli Studi di Milano (Milan, Italy), where she was involved in biopharmaceutics and pharmaceutical technology topics since early 2000s. She is trained in classical technology related to the development of orally-administered drug delivery systems and has developed specific expertise in the field of hot-processing techniques, injection molding and 3D printing by fused deposition modeling (FDM). She has authored or co-authored about hundred research papers which have been published in international journals, approximately 150 extended abstracts that were collected in peer reviewed congress proceedings, and a few patents. One of her current main research interests is the prospective application of 4D printing in the field of drug delivery.
iMed.ULisboa—Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Portugal
João F. Pinto is Associate Professor at the Faculty of Pharmacy of University of Lisbon and holds a PhD Degree in Pharmaceutical Technology (University of London). His main interests are focused on the study of solid state of materials for pharmaceutical /medicinal applications. This encompasses the establishment of relationships between the molecular and bulk levels of materials supporting the manufacture of dosage forms (e.g. free flowing powders, granules, tablets, capsules) either by conventional or novel (e.g. 3D printing) technologies. In this respect solubility related issues and drug bioavailability are core to the work carried out in the lab. He is a member of different associations (AAPS, APV, EUFEPS, SPCF), country contact person for the EPTRI (European Pediatric Translational Research Infrastructure) and Un. Lisbon Coordinator within the PSSRC (Pharmaceutical Solid State Research Cluster).
Time in CET
Chair Prof. Dr. Dimitrios A. Lamprou
10:00 - 10:10 am
Dr. Dolores R. Serrano
3D Printing Technologies for Innovative Medicines
10:10 - 10:30 am
Dr. Lucia Zema
4D Printing: The Magic in Pharmaceutics
10:30 - 10:50 am
João F. Pinto
Advantages, Disadvantages and Limitations on Using FDM 3D Printing Technology for the Manufacture of Individualized Medicines
10:50 - 11:10 am
11:10 - 11:25 am
Closing of Webinar
Chair Prof. Dr. Dimitrios A. Lamprou
11:25 - 11:30 am
3D Printing of Pharmaceuticals and Drug Delivery Devices
Guest Editor: Prof. Dr. Dimitrios A. Lamprou
Deadline for manuscript submissions: closed (31 December 2019)
Topical Collection3D Printing and Bioprinting Applications in Pharmaceutics
Collection Editors: Prof. Dr. Dimitrios A. Lamprou and Dr. Eneko Larrañeta Landa